Laxmi Dental

Which are the latest news on Laxmi Dental?

Why is Laxmi Dental Ltd falling/rising?

As of 05-Sep, Laxmi Dental Ltd's stock price is at 199.50, showing a short-term upward trend despite a year-to-date decline of 26.60% and a 40.00% drop over the past year. The recent gains are overshadowed by declining investor participation and underperformance against longer-term averages.

As of 05-Sep, Laxmi Dental Ltd's stock price is currently at 199.50, reflecting a change of 0.7 (0.35%) upward. The stock has been gaining for the last three days, with a total increase of 4.14% during this period, indicating a positive short-term trend. Additionally, it has outperformed its sector by 4.09% today.<BR><BR>However, despite this recent rise, the stock has experienced significant declines over longer periods. Year-to-date, it has fallen by 26.60%, and over the past year, it has decreased by 40.00%. This contrasts with the broader market, represented by the Sensex, which has only declined by 10.21% year-to-date and 5.21% over the past year.<BR><BR>The stock's performance today is also notable as it is higher than the 5-day moving average, although it remains lower than the 20-day, 50-day, 100-day, and 200-day moving averages. This suggests that while there is a short-term upward movement, the stock is still underperforming relative to its longer-term trends.<BR><BR>Investor participation appears to be declining, as evidenced by a drop in delivery volume of 36.92k on September 3, which is down by 18.7% compared to the 5-day average. This decrease in trading activity could indicate waning interest among investors, which may affect future price movements.<BR><BR>In summary, Laxmi Dental Ltd is currently experiencing a rise in stock price due to recent gains and sector outperformance, but it faces significant challenges from its long-term performance and declining investor participation.

What does Laxmi Dental do?

Laxmi Dental Ltd is a micro-cap healthcare services company that specializes in dental care, with recent net sales of 75 Cr and a net profit of 10 Cr as of June 2026. The company was incorporated in 2004 and became public in August 2024.

Overview:<BR>Laxmi Dental Ltd operates in the healthcare services industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Laxmi Dental Limited was incorporated in 2004 as 'Laxmi Dental Export Private Limited'. The company underwent a name change to 'Laxmi Dental Private Limited' in June 2024 and subsequently converted to a public company as 'Laxmi Dental Limited' in August 2024. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 75 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 10 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 1,090 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 29.00 <BR>Industry P/E: 112 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.04 <BR>Return on Equity: 14.29% <BR>Price to Book: 4.57 <BR><BR>Contact Details:<BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the peers of the Laxmi Dental?

Laxmi Dental's peers include Krsnaa Diagnostics, Suraksha Diagnostics, Tarsons Products, 3B Blackbio, One Global Services, Health X Platform, and Hemant Surgical. Laxmi Dental has average management risk, good growth, and a 1-year return of -42.71%.

Peers: The peers of Laxmi Dental are Krsnaa Diagnost., Suraksha Diagno., Tarsons Products, 3B Blackbio, One Global Serv, Health X Platfor, and Hemant Surgical.<BR><BR>Quality Snapshot: Excellent management risk is observed at Suraksha Diagno. and One Global Serv, while Average management risk is found at Krsnaa Diagnost., 3B Blackbio, Laxmi Dental, and Hemant Surgical. Below Average management risk is present at Tarsons Products and Health X Platfor. Growth is Excellent at One Global Serv, Good at Laxmi Dental, Suraksha Diagno., and Hemant Surgical, while Below Average growth is noted at Krsnaa Diagnost., Tarsons Products, 3B Blackbio, and Health X Platfor. Capital Structure is Excellent at Laxmi Dental, One Global Serv, and Health X Platfor, Good at Krsnaa Diagnost. and Hemant Surgical, Average at Tarsons Products, and Below Average at 3B Blackbio.<BR><BR>Return Snapshot: One Global Serv has the highest 1-year return at 111.18%, while Krsnaa Diagnost. has the lowest at -29.39%, with Laxmi Dental's 1-year return at -42.71%, which is lower than both. Additionally, Krsnaa Diagnost., One Global Serv, and Hemant Surgical have negative six-month returns.

How big is Laxmi Dental?

As of 31st August, Laxmi Dental Ltd has a market capitalization of 1,090.00 Cr, with recent Net Sales of 286.96 Cr and a Net Profit of 30.89 Cr. The balance sheet for March 2025 shows Shareholder's Funds of 208.54 Cr and Total Assets of 278.22 Cr.

As of 31st August, Laxmi Dental Ltd has a market capitalization of 1,090.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Laxmi Dental reported Net Sales of 286.96 Cr and a Net Profit of 30.89 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing Shareholder's Funds of 208.54 Cr and Total Assets of 278.22 Cr.

Should I buy, sell or hold Laxmi Dental Ltd?

Are Laxmi Dental Ltd latest results good or bad?

Laxmi Dental Ltd's Q4 FY26 results show strong revenue growth of 21.89% year-on-year and a significant net profit increase of 409.09% quarter-on-quarter. However, concerns about margin volatility suggest investors should exercise caution and monitor future performance closely.

Laxmi Dental Ltd's latest results for Q4 FY26 present a mixed picture. On one hand, the company achieved a robust revenue of ₹73.95 crores, reflecting an 11.98% sequential increase and a significant 21.89% year-on-year growth. The net profit also saw a remarkable recovery, soaring by 409.09% quarter-on-quarter to ₹10.08 crores, indicating strong underlying demand and operational improvements.<BR><BR>However, there are notable concerns regarding margin volatility. The operating profit margin fluctuated dramatically from 10.87% in the previous quarter to 18.70% in Q4, raising questions about the sustainability of this profitability. Such swings in margins can indicate operational inconsistency, which investors should monitor closely.<BR><BR>Overall, while the headline numbers are impressive and suggest strong growth potential, the significant margin volatility and operational inconsistency warrant caution. Investors may want to wait for more consistent performance in upcoming quarters before making any decisions.

When is the next results date for Laxmi Dental Ltd?

The next results date for Laxmi Dental Ltd is 10 February 2026.

The next results date for Laxmi Dental Ltd is scheduled for 10 February 2026.

Is Laxmi Dental overvalued or undervalued?

As of December 4, 2025, Laxmi Dental is considered overvalued with a high PE ratio of 57.86 and other elevated valuation metrics, despite respectable returns on capital and equity, and has underperformed the Sensex recently.

As of 4 December 2025, Laxmi Dental has moved from a fair to an expensive valuation grade. The company is currently overvalued, as indicated by its high PE ratio of 57.86, a Price to Book Value of 6.75, and an EV to EBITDA of 36.56. In comparison to its peers, Laxmi Dental's valuation metrics are significantly higher, with Lenskart Solutions having a PE of 237.94 and Poly Medicure at 53.38, both categorized as very expensive.<BR><BR>The company's return on capital employed (ROCE) stands at 12.57% and return on equity (ROE) at 11.66%, which, while respectable, do not justify the current high valuation. Recent stock performance shows Laxmi Dental's price has fluctuated, with a current price of 281.40, but it has underperformed the Sensex over the past month, which could reinforce concerns about its valuation. Overall, Laxmi Dental appears to be overvalued in the current market context.

How has been the historical performance of Laxmi Dental?

Laxmi Dental has shown significant growth over the past three years, with net sales increasing from 161.63 Cr in Mar'23 to 239.11 Cr in Mar'25, and profit after tax turning from a loss of 4.45 Cr to a profit of 25.37 Cr. The company's operating profit margin improved from 5.54% to 17.7%, reflecting a strengthening financial position.

Answer:<BR>The historical performance of Laxmi Dental shows significant growth over the past three years, particularly in revenue and profitability.<BR><BR>Breakdown:<BR>Laxmi Dental's net sales have increased from 161.63 Cr in Mar'23 to 239.11 Cr in Mar'25, reflecting a strong upward trend. The total operating income has followed suit, rising from 161.63 Cr in Mar'23 to 239.11 Cr in Mar'25. The company's operating profit (PBDIT) has also seen substantial growth, moving from 11.17 Cr in Mar'23 to 45.21 Cr in Mar'25, with an operating profit margin that improved from 5.54% to 17.7% over the same period. Profit before tax turned positive, reaching 31.83 Cr in Mar'25, compared to a loss of 4.26 Cr in Mar'23, while profit after tax rose from a loss of 4.45 Cr to a profit of 25.37 Cr. The consolidated net profit increased from a loss of 3.97 Cr in Mar'23 to 31.77 Cr in Mar'25. On the balance sheet, total assets grew significantly from 96.38 Cr in Mar'23 to 278.22 Cr in Mar'25, driven by increases in cash and bank balances and total reserves. Total liabilities also rose, but at a slower pace, from 96.38 Cr to 278.22 Cr, indicating a strengthening financial position. Cash flow from operating activities improved dramatically, reaching 43 Cr in Mar'25, compared to only 8 Cr in Mar'24, contributing to a net cash inflow of 125 Cr in Mar'25, a significant turnaround from previous years.

Who are the top shareholders of the Laxmi Dental?

The top shareholders of Laxmi Dental include promoters, with Rajesh Vrajlal Khakhar holding 16.91%, and 27 Foreign Institutional Investors (FIIs) owning 34.24%. The highest public shareholder is Orbimed Asia II Mauritius Limited at 22.41%, while individual investors hold 6.49%.

The top shareholders of Laxmi Dental include a mix of promoters, institutional investors, and public shareholders. The majority shareholders are the promoters, with Rajesh Vrajlal Khakhar holding the highest stake at 16.91%. Among institutional investors, 27 Foreign Institutional Investors (FIIs) collectively hold 34.24%, while 16 mutual fund schemes account for 11.89% of the shares. The highest public shareholder is Orbimed Asia II Mauritius Limited, which holds 22.41%. Additionally, individual investors have a combined holding of 6.49%.

Has Laxmi Dental declared dividend?

No Dividend History Available